1:00 PM - 2:00 PM
Senior Product Manager Interview
Sarah Jenkins

CSL Behring
·4 days agoCSL Behring
·4 days agoLocation
onsite, Broadmeadows, VIC, Australia
Commitment
Full Time
Level
Junior (<2 years)
CSL Behring is seeking two experienced and motivated leaders to join our AlbuRx Bulk Operations team in Broadmeadows:
Both roles are fixed term until 30 September 2027. The Routine Manufacturing role will be reporting to the Senior Manager, Bulk Manufacturing, and the Project role will be reporting to the Process Specialist & Manufacturing Lead.
The AlbuRx Bulk Supervisor is responsible for leading daily manufacturing operations, ensuring activities are delivered safely, efficiently and in compliance with GMP requirements. The role plays a critical part in delivering manufacturing schedules, developing team capability, driving continuous improvement and supporting operational excellence across the AlbuRx Bulk Manufacturing area.
The fixed-term project position will have an additional focus on integrating Operational Readiness activities and supporting engineering, validation and technology transfer activities.
At CSL, our work helps save lives and improve the health of people around the world. This is an exciting opportunity to join a global biotechnology leader and make a meaningful impact while developing your leadership career in a collaborative and purpose-driven environment.
Please submit your application, including your CV, as a single document. Please indicate in your application whether you are interested in the Fixed Term Routine Manufacturing Permanent role, the Fixed-Term Project role, or both.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging.
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.